120 related articles for article (PubMed ID: 15537373)
1. Colorectal cancer and Coxibs.
Taxonera C; Mendoza JL
Rev Esp Enferm Dig; 2004 Oct; 96(10):673-5; 675-7. PubMed ID: 15537373
[No Abstract] [Full Text] [Related]
2. Influence of rofecoxib on experimental colonic carcinogenesis in rats.
Noguera Aguilar JF; Plaza Martínez A; Amengual Antich I; Morón Canis JM; Tortajada Collado C; Pujol Tugores JJ
Rev Esp Enferm Dig; 2004 Oct; 96(10):678-82; 683-6. PubMed ID: 15537374
[TBL] [Abstract][Full Text] [Related]
3. [Aspirin and PIK3CA mutation in colorectal cancer].
Kirstein MM; Vogel A
Z Gastroenterol; 2014 Mar; 52(3):306-7. PubMed ID: 24622874
[No Abstract] [Full Text] [Related]
4. A trial of adjuvant therapy in colorectal cancer: the VICTOR trial.
Pendlebury S; Duchesne F; Reed KA; Smith JL; Kerr DJ
Clin Colorectal Cancer; 2003 May; 3(1):58-60. PubMed ID: 12777194
[No Abstract] [Full Text] [Related]
5. Aspirin therapy for colorectal cancer with PIK3CA mutation: simply complex!
Fuchs CS; Ogino S
J Clin Oncol; 2013 Dec; 31(34):4358-61. PubMed ID: 24166520
[No Abstract] [Full Text] [Related]
6. What happened to the coxibs on the way to the cardiologist?
Alberts DS; Potter JD; Martinez ME; Hess LM; Stopeck A; Lance P
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):555-6. PubMed ID: 15767326
[No Abstract] [Full Text] [Related]
7. Effect of rofecoxib on colon chemical carcinogenesis at colonic anastomotic area in the rat.
Noguera Aguilar JF; Amengual Antich I; Morón Canis JM; Plaza Martínez A; Martínez Córcoles JA; Tortajada Collado C; Pujol Tugores JJ
Rev Esp Enferm Dig; 2005 Jun; 97(6):405-15. PubMed ID: 16011415
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2 inhibitors in aspirin-induced asthma.
Inoue K; Takano H; Kawahito Y; Sano H; Yoshikawa T
Chest; 2003 Apr; 123(4):1317-8; author reply 1318. PubMed ID: 12684334
[No Abstract] [Full Text] [Related]
9. Increased risk of cardiovascular events with coxibs and NSAIDs.
Scott DG; Watts RA
Lancet; 2005 Apr 30-May 6; 365(9470):1537. PubMed ID: 15866299
[No Abstract] [Full Text] [Related]
10. [Minor rate of side-effects makes it possible. Coxibs accrue new indications].
MMW Fortschr Med; 2004 Aug; 146(31-32):49. PubMed ID: 15529715
[No Abstract] [Full Text] [Related]
11. COX-2 inhibitors and hypercoagulability.
Farkouh ME
Clin Adv Hematol Oncol; 2005 Jan; 3(1):35-6. PubMed ID: 16166966
[No Abstract] [Full Text] [Related]
12. [VIOXX written off--and what next? COX-2 inhibitors and cardiovascular diseases].
Jerie P
Cas Lek Cesk; 2005; 144(1):4. PubMed ID: 15789774
[No Abstract] [Full Text] [Related]
13. Exploring the potential chemopreventative effect of aspirin and rofecoxib on hereditary nonpolyposis colorectal cancer-like endometrial cancer cells in vitro through mechanisms involving apoptosis, the cell cycle, and mismatch repair gene expression.
Wood NJ; Quinton NA; Burdall S; Sheridan E; Duffy SR
Int J Gynecol Cancer; 2007; 17(2):447-54. PubMed ID: 17316360
[TBL] [Abstract][Full Text] [Related]
14. [The rise and fall of Vioxx: society, values and their choice].
Caspi D
Harefuah; 2004 Nov; 143(11):770-1. PubMed ID: 15603261
[No Abstract] [Full Text] [Related]
15. [Is there a future for COX-2 inhibitors?].
Yodfat Y
Harefuah; 2004 Nov; 143(11):820-4, 837. PubMed ID: 15603272
[TBL] [Abstract][Full Text] [Related]
16. Health Canada lukewarm on Vioxx panel findings.
Murray S
CMAJ; 2005 Aug; 173(4):350. PubMed ID: 16103502
[No Abstract] [Full Text] [Related]
17. Rofecoxib as an alternative in aspirin hypersensitivity.
Hinrichs R; Ritzkowsky A; Hunzelmann N; Krieg T; Scharffetter-Kochanek K
Allergy; 2001 Aug; 56(8):789. PubMed ID: 11488679
[No Abstract] [Full Text] [Related]
18. Don't throw out the baby with the bathwater!
Kamen B; Kieran M
J Pediatr Hematol Oncol; 2005 Feb; 27(2):59-60. PubMed ID: 15701976
[No Abstract] [Full Text] [Related]
19. The coxibs, selective inhibitors of cyclooxygenase-2.
FitzGerald GA; Patrono C
N Engl J Med; 2001 Aug; 345(6):433-42. PubMed ID: 11496855
[No Abstract] [Full Text] [Related]
20. COX-2 inhibitors still eyed for cancer prevention.
Thompson CA
Am J Health Syst Pharm; 2005 May; 62(9):890, 894. PubMed ID: 15851492
[No Abstract] [Full Text] [Related]
[Next] [New Search]
